Application Sponsors
ANDA 079080 | ACTAVIS LABS FL INC | |
Marketing Status
Application Products
001 | TABLET, DELAYED RELEASE;ORAL | EQ 500MG VALPROIC ACID | 0 | DIVALPROEX SODIUM | DIVALPROEX SODIUM |
FDA Submissions
| ORIG | 1 | AP | 2011-02-25 | |
LABELING; Labeling | SUPPL | 2 | AP | 2020-10-19 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2020-10-19 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2020-10-19 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2020-10-19 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 1 |
SUPPL | 2 | Null | 15 |
SUPPL | 3 | Null | 15 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 7 |
TE Codes
CDER Filings
ACTAVIS LABS FL INC
cder:Array
(
[0] => Array
(
[ApplNo] => 79080
[companyName] => ACTAVIS LABS FL INC
[docInserts] => ["",""]
[products] => [{"drugName":"DIVALPROEX SODIUM","activeIngredients":"DIVALPROEX SODIUM","strength":"EQ 500MG VALPROIC ACID","dosageForm":"TABLET, DELAYED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"DIVALPROEX SODIUM","submission":"DIVALPROEX SODIUM","actionType":"EQ 500MG VALPROIC ACID","submissionClassification":"TABLET, DELAYED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)